Werewolf Therapeutics
Werewolf Therapeutics, based in Watertown, Massachusetts, specializes in developing innovative cancer therapies using its proprietary PREDATOR™ protein engineering technology to create INDUKINE™ molecules, aimed at enhancing cancer treatment efficacy while reducing off-target effects.
Company Overview
Werewolf Therapeutics is a biotechnology company headquartered in Watertown, Massachusetts, specializing in the development of transformative cancer therapies. The company focuses on creating targeted biotherapeutics that aim to maximize therapeutic potential while minimizing unwanted off-target effects. Their approach is grounded in advanced protein engineering techniques, specifically utilizing their proprietary PREDATOR™ technology.
Innovative Cancer Therapies
Werewolf Therapeutics is advancing a novel class of cancer biotherapeutics known as INDUKINE™ molecules. These molecules are conditionally activated proinflammatory immune modulators designed to be administered systemically in an inactive form and selectively activated within the tumor microenvironment. This targeted activation approach aims to enhance efficacy while reducing harmful side effects associated with traditional cancer treatments.
Proprietary Technologies
The cornerstone of Werewolf Therapeutics' innovation is their PREDATOR™ protein engineering technology. This proprietary technology enables the precise design and engineering of immuno-oncology biotherapeutics. PREDATOR™ allows the company to craft therapies that activate specifically in the tumor microenvironment, leveraging the body's own immune system to fight cancer more effectively.
Product Pipeline
Werewolf Therapeutics' pipeline includes several promising products targeting various aspects of cancer treatment. These include WTX-124, WTX-330, JZP898 (formerly WTX-613), WTX-712, and WTX-518. Each product in the pipeline is designed to address specific therapeutic needs in oncology, driven by the company's commitment to developing innovative and effective cancer therapies.
Location and Headquarters
Werewolf Therapeutics is based in Watertown, Massachusetts. This strategic location places them in a vibrant biotech hub that fosters innovation and collaboration in the development of groundbreaking medical technologies and therapies.